SM
BCLI

Sabby Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-136,484
Closed -$27.3K 50
2023
Q3
$27.3K Sell
136,484
-1,131,387
-89% -$226K 0.02% 57
2023
Q2
$2.61M Buy
+1,267,871
New +$2.61M 2.14% 1
2022
Q1
Sell
-513,211
Closed -$2.05M 91
2021
Q4
$2.05M Buy
513,211
+36,886
+8% +$148K 0.3% 31
2021
Q3
$1.57M Buy
476,325
+233,475
+96% +$771K 0.21% 31
2021
Q2
$923K Buy
242,850
+106,240
+78% +$404K 0.13% 47
2021
Q1
$523K Buy
+136,610
New +$523K 0.1% 55
2020
Q4
Hold
0
59
2020
Q3
Hold
0
73
2020
Q2
Hold
0
56
2020
Q1
Hold
0
60
2019
Q4
Hold
0
53
2019
Q3
Sell
-158,152
Closed -$625K 68
2019
Q2
$625K Sell
158,152
-587,053
-79% -$2.32M 0.79% 18
2019
Q1
$3.23M Sell
745,205
-265,477
-26% -$1.15M 1.55% 2
2018
Q4
$3.59M Buy
1,010,682
+103,726
+11% +$368K 0.79% 5
2018
Q3
$3.47M Sell
906,956
-22,769
-2% -$87K 0.44% 10
2018
Q2
$3.63M Buy
929,725
+907,402
+4,065% +$3.54M 0.56% 9
2018
Q1
$70K Buy
+22,323
New +$70K 0.01% 77
2017
Q3
Sell
-16,731
Closed -$70K 90
2017
Q2
$70K Sell
16,731
-52,813
-76% -$221K ﹤0.01% 100
2017
Q1
$296K Sell
69,544
-181,222
-72% -$771K 0.02% 96
2016
Q4
$637K Sell
250,766
-193,734
-44% -$492K 0.04% 80
2016
Q3
$1.06M Sell
444,500
-32,219
-7% -$77K 0.04% 65
2016
Q2
$1.15M Sell
476,719
-16,472
-3% -$39.7K 0.06% 66
2016
Q1
$1.32M Sell
493,191
-276,343
-36% -$738K 0.07% 70
2015
Q4
$2.2M Sell
769,534
-82,814
-10% -$237K 0.12% 38
2015
Q3
$1.95M Buy
852,348
+108,701
+15% +$249K 0.08% 66
2015
Q2
$2.69M Sell
743,647
-665,890
-47% -$2.4M 0.1% 46
2015
Q1
$6.27M Buy
+1,409,537
New +$6.27M 0.26% 15
2014
Q4
Sell
-808,256
Closed -$3.32K 116
2014
Q3
$3.32K Buy
+808,256
New +$3.32K 0.13% 21